Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 21:8:45-54.
doi: 10.2147/RMHP.S56911. eCollection 2015.

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature

Silvia Coretti  1 , Federica Romano  1 , Valentina Orlando  2 , Paola Codella  1 , Sabrina Prete  1 , Eugenio Di Brino  1 , Matteo Ruggeri  1
Affiliations
Review

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature

Silvia Coretti et al. Risk Manag Healthc Policy. .

Abstract

Background: Hepatitis C is a liver infection caused by hepatitis C virus. Its main complications are cirrhosis and liver cancer. According to the World Health Organization (WHO), more than 185 million people worldwide are infected with hepatitis C virus and, of these, 350,000 die every year. Due to the high disease prevalence and the existence of effective (and expensive) medical treatments able to dramatically change the prognosis, early detection programs can potentially prevent the development of serious chronic conditions, improve health, and save resources.

Objective: To summarize the available evidence on the cost-effectiveness of screening programs for hepatitis C.

Methods: A literature search was performed on PubMed and Scopus search engines. Trip database was queried to identify reports produced by the major Health Technology Assessment (HTA) agencies. Three reviewers dealt with study selection and data extraction blindly.

Results: Ten papers eventually met the inclusion criteria. In studies focusing on asymptomatic cohorts of individuals at general risk the cost/quality adjusted life year of screening programs ranged between US $4,200 and $50,000/quality adjusted life year gained, while in those focusing on specific risk factors the incremental cost-effectiveness ratio ranged between $848 and $128,424/quality adjusted life year gained. Age of the target population and disease prevalence were the main cost-effectiveness drivers.

Conclusion: Our results suggest that, especially in the long run, screening programs represent a cost-effective strategy for the management of hepatitis C.

Keywords: cost-effectiveness; early detection; hepatitis C; screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the study selection process.
See this image and copyright information in PMC

References

    1. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011;55(2):245–264. - PubMed
    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of Hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–1342. - PubMed
    1. Lavanchy D. The global burden of Hepatitis C. Liver Int. 2009;29(Suppl 1):74–81. - PubMed
    1. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271–278. - PubMed
    1. Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C Virus into 7 genotypes and 67 Subtypes: updated criteria and assignment web resource. Hepatology. 2014;59(1):318–327. - PMC - PubMed